Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Tdspharm Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩14,260.00 |
52 Week High | ₩60,700.00 |
52 Week Low | ₩13,900.00 |
Beta | 0 |
11 Month Change | -31.11% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -72.58% |
Recent News & Updates
Recent updates
Shareholder Returns
A464280 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | -11.9% | -5.7% | -1.0% |
1Y | n/a | 33.7% | 9.5% |
Return vs Industry: Insufficient data to determine how A464280 performed against the KR Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how A464280 performed against the KR Market.
Price Volatility
A464280 volatility | |
---|---|
A464280 Average Weekly Movement | 20.0% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 6.8% |
10% most volatile stocks in KR Market | 12.2% |
10% least volatile stocks in KR Market | 3.6% |
Stable Share Price: A464280's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: Insufficient data to determine A464280's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | n/a | n/a | www.tdspharm.com |
Tdspharm Co., Ltd. Fundamentals Summary
A464280 fundamental statistics | |
---|---|
Market cap | ₩78.86b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A464280 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A464280 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A464280 perform over the long term?
See historical performance and comparison